Amphastar Pharmaceuticals, Inc. (AMPH)
25.87
-0.55
(-2.08%)
USD |
NASDAQ |
Oct 16, 16:00
25.86
-0.01
(-0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Investing (Quarterly) : 44.87M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.87M |
| March 31, 2026 | -16.73M |
| December 31, 2025 | -60.57M |
| September 30, 2025 | -19.62M |
| June 30, 2025 | -0.625M |
| March 31, 2025 | 10.48M |
| December 31, 2024 | -35.68M |
| September 30, 2024 | -34.59M |
| June 30, 2024 | -69.90M |
| March 31, 2024 | 15.24M |
| December 31, 2023 | -103.05M |
| September 30, 2023 | -31.15M |
| June 30, 2023 | -508.58M |
| March 31, 2023 | -6.333M |
| December 31, 2022 | -0.229M |
| September 30, 2022 | -15.26M |
| June 30, 2022 | -8.18M |
| March 31, 2022 | -9.11M |
| December 31, 2021 | -11.95M |
| September 30, 2021 | -3.769M |
| June 30, 2021 | -4.254M |
| March 31, 2021 | -8.695M |
| December 31, 2020 | -12.18M |
| September 30, 2020 | -5.451M |
| June 30, 2020 | -10.07M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.722M |
| December 31, 2019 | -7.352M |
| September 30, 2019 | -18.62M |
| June 30, 2019 | -9.669M |
| March 31, 2019 | -14.88M |
| December 31, 2018 | -8.797M |
| September 30, 2018 | -12.88M |
| June 30, 2018 | -11.77M |
| March 31, 2018 | -8.738M |
| December 31, 2017 | -10.13M |
| September 30, 2017 | -12.97M |
| June 30, 2017 | -6.926M |
| March 31, 2017 | -5.965M |
| December 31, 2016 | -7.113M |
| September 30, 2016 | -14.96M |
| June 30, 2016 | -7.901M |
| March 31, 2016 | -9.42M |
| December 31, 2015 | -4.669M |
| September 30, 2015 | -3.702M |
| June 30, 2015 | -3.719M |
| March 31, 2015 | -5.045M |
| December 31, 2014 | -9.928M |
| September 30, 2014 | -3.13M |
| June 30, 2014 | -21.92M |
| March 31, 2014 | -4.797M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Viatris, Inc. | -51.60M |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | -15.40B |
| Merck & Co., Inc. | -5.602B |
| Pfizer Inc. | 2.106B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 51.32M |
| Cash from Financing (Quarterly) | -43.54M |
| Free Cash Flow | 152.89M |
| Free Cash Flow Per Share (Quarterly) | 0.9663 |
| Free Cash Flow to Equity (Quarterly) | 40.79M |
| Free Cash Flow to Firm (Quarterly) | 47.98M |
| Free Cash Flow Yield | 12.74% |